Calcium folinate pentahydrate
Mucinous Adenocarcinoma of the Rectum
University of Southern CaliforniaSmall moleculePhase 3Dormant
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 60/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Mucinous Adenocarcinoma of the Rectum cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUOROURACILUM University of Southern California | Phase 3 | BBB |
Irinotecan Fox Chase Cancer Center | Phase 3 | BBB |
Eloxatin Virginia Commonwealth University | Phase 3 | BBB |
(+)-VINCRISTINE University of Southern California | Phase 2 | B |
Aflibercept John Hays | Phase 2 | B |
View all 23 →
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →